typical dose bpc-157 Dosing Guide: Protocol, Reconstitution & Safety (2026) BPC-157: Benefits & Dosage Guide

Importantly, the standard anti-glaucomatous agents on the increased intraocular pressure had delayed onset [155,156,157,158,159,160,161,162], and in some experimental studies, the effect can be absent [163], or even the opposite effect [164]

BPC-157 is a synthetic pentadecapeptide derived from a sequence associated with gastric protective proteins and has been explored for its apparent influence on angiogenic signaling, nitric oxide pathways, and cellular migration in vitro

The NICE Guideline NG239 (2024) and the AAFP clinical review both support this approach

injections are chosen for rapid repletion or malabsorption

Subcutaneous is the standard for self-administered BPC-157 knee protocols